We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MA:NYSEMastercard Incorporated Analysis

Data as of 2026-04-16 - not real-time

$519.96

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mastercard (MA) trades at $519.96, marginally above its DCF fair value of $503, and sits between its 20‑day SMA ($499.6) and 50‑day SMA ($513.0) while still below the 200‑day SMA ($551.3), indicating a short‑term pull‑back within a longer‑term uptrend. The RSI of 58.7 suggests modest upward momentum but not overbought, and the MACD histogram (+3.4) signals a bullish crossover despite a bearish overall trend direction. Volume is decreasing, and the stock is testing resistance around $522.4 with support near $480.5, framing a tight trading range. Fundamentally, MA delivers strong earnings growth (17.6% revenue growth, forward EPS up 37% YoY) and high profitability (57.7% operating margin), but its PE of 31.5× far exceeds the industry average of 17.6×, implying an overvalued valuation today.
Recent material news includes the $1.8 B BVNK acquisition, a successful pilot of authenticated agentic transactions in Malaysia, and ongoing litigation over interchange fees, which could impact margins. The dividend remains modest at 0.67% with an 18% payout ratio, supported by robust cash flow. Analyst sentiment is heavily bullish (strong‑buy, median target $665), and the Fear & Greed Index at 88.98 reflects “Extreme Greed,” suggesting heightened market enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with decreasing volume
  • Bearish trend direction despite bullish MACD signal
  • Potential short‑term volatility (23% 30‑day)

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings growth and high operating margins
  • Strategic acquisition (BVNK) expanding digital capabilities
  • Analyst consensus strong‑buy with median price target $665

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by cash flow
  • Global network reducing geographic concentration risk
  • Long‑run upside potential (~26% above current price) per DCF and analyst targets

Key Metrics & Analysis

Financial Health

Revenue Growth17.60%
Profit Margin45.65%
P/E Ratio31.5
ROE209.91%
ROA23.72%
Debt/Equity256.04
P/B Ratio60.1
Op. Cash Flow$17.6B
Free Cash Flow$16.3B
Industry P/E17.6

Technical Analysis

TrendBearish
RSI58.7
Support$480.50
Resistance$522.43
MA 20$499.63
MA 50$513.01
MA 200$551.28
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Fair Value$503.56
Target Price$654.66
Upside/Downside25.91%
GradeOvervalued
TypeGrowth
Dividend Yield0.67%

Risk Assessment

Beta0.71
Volatility23.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.